SH

Sudhir Haridas Borkar

Active Director Director DIN 08001409
DIN 08001409 First appointment Jan 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Sudhir Haridas Borkar

Data last updated:

Sudhir Haridas Borkar is a Director at Sarvadnya Nucleus Hospital & Research Center Private Limited (since 2018). The company operates in Healthcare.

DIN 08001409
Primary Designation Director
Industry Healthcare
First Appointment 16 Jan 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jan 20182018Active

Directorship timeline

Open interactive timeline →
Sarvadnya Nucleus Hospital & Research Center Private Limited
Premium access

Shareholding and investment profile for Sudhir Haridas Borkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhir Haridas Borkar

Sudhir Haridas Borkar currently holds 1 directorship: Sarvadnya Nucleus Hospital & Research Center Private Limited (Director, since 16 Jan 2018).

Sudhir Haridas Borkar was first appointed on 16 Jan 2018 as Director at Sarvadnya Nucleus Hospital & Research Center Private Limited.

The current boards of Sudhir Haridas Borkar's companies include Gopal Dilippant Bahurupi (Sarvadnya Nucleus Hospital & Research Center Private Limited), Pramod Vitthal Jadhav (Sarvadnya Nucleus Hospital & Research Center Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available